The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis Journal title: Türkiye Osteoporoz Dünyasından Authors: İlker Çorapçı, Cengiz Öner, Onur Armağan, Yavuz Pehlivan, Funda Taşçıoğlu Subject(s):
Postmenopozal Osteoporoz Tedavisinde Haftalık 70 Mg ve Günlük 10 Mg Alendronat Tedavisinin Etkinliği Journal title: Türkiye Osteoporoz Dünyasından Authors: İlker Çorapçı, Cengiz Öner, Onur Armağan, Yavuz Pehlivan, Funda Taşçıoğlu Subject(s):
The Comparison of Effects of Alendronate and Raloxifene Treatment in<br /> Postmenopausal Women with Osteoporosis Journal title: Türkiye Osteoporoz Dünyasından Authors: Gülcan Gürer, Faruk Şendur, Cavidan Ay, Ayhan Erkek, Bengü Odabaşı Subject(s):
Osteoporoz ve Diz Osteoartritinin Birlikte Bulunduğu Hastalarda Diz Semptomları Üzerine Haftalık Alendronatın Etkinliği Journal title: Türkiye Osteoporoz Dünyasından Authors: Levent Ediz, Özcan Hız, Murat Toprak, İbrahim Tekeoğlu Subject(s):
Alendronate a promising / multi aspect drug in the management of ostoeoporosis Journal title: Pakistan Journal of Pharmacology Authors: Shehla Shaheen, Qamaruddin Barakzai, Syed Noor, Mansoor Khan Subject(s):
Proton pump (H(+)/K(+)-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats. Journal title: Pharmacological Reports Authors: Maria Pytlik, Urszula Cegieła, Joanna Folwarczna, Barbara Nowińska Subject(s):
EFFECT OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS VS ALENDRONATE SODIUM IN TREATMENT OF INDUCED ESTROGEN DEFICIENCY OSTEOPOROSIS IN ALVEOLAR BONE OF ALBINO RATS. Journal title: International Journal of Advanced Research (IJAR) Authors: Marwa M. Abd El Hameed, Iman A. Fathy. Subject(s):
Subtrochanteric Fracture In A Chinese Woman With Paget’s Disease Of Bone And On Long Term Bisphosphonate Therapy: Could It Be An Insufficiency Fracture? Journal title: Malaysian Orthopaedic Journal Authors: CK Lee, P Jeremy, S Simmrat, M Azura Subject(s):
Spontaneous Subtrochanteric Femoral Stress Fracture Related to Alendronate : A Case Report Journal title: Malaysian Orthopaedic Journal Authors: Paul CC Chew, B Julaihi, ZA Ibrahim Subject(s):
Femoral Shaft Cortical Pathology associated with longterm Alendronate Therapy: A New Classification Journal title: Malaysian Orthopaedic Journal Authors: MK Kwan, CK Chan, WM Ng, AM Merican, SP Chan Subject(s):
Bisphosphonate-Associated Bilateral Atraumatic Ulna Fractures Journal title: International Journal of Medical and Pharmaceutical Case Reports Authors: W. Banks Hinshaw, Jennifer P. Schneider Subject(s):
Transient Osteoporosis of the Hip: A Case Report Journal title: Malaysian Orthopaedic Journal Authors: Pande K, Aung TT, Leong JF, Bickle I Subject(s):
Atypical Femoral Fractures Following Use of Intravenous Zoledronic Acid After Prior Treatment with Alendronate: A Clinical Practice Series and Opinion Journal title: International Journal of Medical and Pharmaceutical Case Reports Authors: W. Banks Hinshaw, Jennifer P. Schneider Subject(s):
Bisphosphonate-associated Atypical Fractures that are not “Atypical Femoral Fractures” Journal title: Journal of Advances in Medicine and Medical Research Authors: W. Banks Hinshaw, Jennifer P. Schneider Subject(s):
Chronic Oral Alendronate Use is Associated with Gastrointestinal Reflux Disease and Voice Alterations Irrespective of the Presence of Esophagitis Journal title: Journal of Advances in Medicine and Medical Research Authors: A. C. Araujo, N. Lobo, S. Barbosa, E. Bandeira, F. Bandeira Subject(s):
